QIAGEN GmbH · Class II · Cleared Oct 29, 2024
| K-number | K242256 |
| Device name | QIAstat-Dx Meningitis/Encephalitis (ME) Panel |
| Applicant | QIAGEN GmbH |
| Product code | PLO |
| Device class | Class II |
| Decision date | Oct 29, 2024 |
| Decision | Substantially Equivalent |
| Regulation | 866.3970 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov